ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,411Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 917

$565K Total Retail Price of All Prescriptions

Rank: 84 out of 917

566 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 566 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 566 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,841 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 521 420 1 2
LISINOPRIL 388 271 2 1
AMLODIPINE BESYLATE 324 264 3 5
METOPROLOL TARTRATE 324 255 3 11
WARFARIN SODIUM 298 257 5 10
LEVOTHYROXINE SODIUM 297 221 6 3
METFORMIN HCL 262 171 7 8
HYDROCHLOROTHIAZIDE 250 194 8 9
FUROSEMIDE 225 182 9 7
OMEPRAZOLE 193 145 10 4
CITALOPRAM HBR 188 111 11 15
POTASSIUM CHLORIDE 165 133 12 16
LANTUS 155 130 13 37
HYDROCODONE-ACETAMINOPHEN 154 102 S3 14 6
TRAZODONE HCL 153 107 15 22
ALENDRONATE SODIUM 142 109 16 23
GABAPENTIN 141 84 17 17
TAMSULOSIN HCL 138 123 18 25
METOPROLOL SUCCINATE 127 106 19 18
LOVASTATIN 119 70 20 19
RANITIDINE HCL 104 75 21 29
PRAVASTATIN SODIUM 99 86 22 20
TRAMADOL HCL 98 46 23 28
FLUTICASONE PROPIONATE 97 66 24 26
CRESTOR 87 56 25 30
GLIPIZIDE 87 57 25 40
AGGRENOX 85 73 27 186
PANTOPRAZOLE SODIUM 85 47 27 44
CARVEDILOL 80 56 29 33
PROAIR HFA 75 33 30 35
ATENOLOL 72 52 31 12
ATORVASTATIN CALCIUM 70 65 32 14
LANTUS SOLOSTAR 67 36 33 63
ACETAMINOPHEN-CODEINE 66 27 S3 34 109
CIPROFLOXACIN HCL 66 58 34 72
SPIRIVA 60 36 36 45
FINASTERIDE 60 60 36 77
LOSARTAN POTASSIUM 60 56 36 13
DIGOXIN 58 44 39 41
CYCLOBENZAPRINE HCL 57 19 R 40 65
SERTRALINE HCL 55 49 41 24
INSULIN SYRINGE 54 32 42 83
ACTOS 53 40 43 112
GEMFIBROZIL 52 20 44 140
AZITHROMYCIN 52 34 44 61
NAMENDA 50 50 46 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.